Ferring Pharmaceuticals:

News Archives

06/21/2010

“Ferring Pharmaceuticals Announces Immediate Availability Of Lysteda™, The First Non-Hormonal Therapy Indicated Specifically For Cyclic Heavy Menstrual Bleeding ”

Information for Patients and Physicians Available at www.lysteda.com Parsippany, NJ – June 21...

05/19/2010

“CLINICAL DATA DEMONSTRATES THAT LYSTEDA™ SIGNIFICANTLY REDUCED MENSTRUAL BLOOD LOSS AND LIMITATIONS ON SOCIAL, LEISURE AND PHYSICAL ACTIVITIES IN WOMEN WITH CYCLIC HMB”

Ferring presents findings at The American College of Obstetricians and Gynecologists 58th Annual Cli...

05/10/2010

“FERRING ACQUIRES LYSTEDA™ FROM XANODYNE PHARMACEUTICALS, INC.”

Global Acquisition Expands Ferring’s Role in Women’s Health SAINT-PREX, Switzerland &nd...

04/01/2010

“XANODYNE AND FERRING ANNOUNCE CO-PROMOTE FOR ZIPSOR™”

NEWPORT, Ky. and PARSIPPANY, N.J., April 1 /PRNewswire/ – Xanodyne Pharmaceuticals, Inc., an i...

03/08/2010

“NEW ARTICLE REVEALS TREND TOWARD GREATER USE OF HUMAN MENOPAUSAL GONADOTROPIN IN IN VITRO FERTILIZATION ”

Review Article of hMG Published in US Obstetrics & Gynecology PARSIPPANY, NJ – March 8, 2...

03/01/2010

“WIN A $10,000 EDUCATION FUND FOR YOUR MIRACLE CHILD”

Ferring Pharmaceuticals Announces 2010 My Little Miracle Essay Contest PARSIPPANY, NJ – March...

02/25/2010

“FERRING PHARMACEUTICALS AND GENE SECURITY NETWORK PARTNER TO TEST ADVANCED PREIMPLANTATION GENETIC DIAGNOSIS (PGD) TECHNOLOGY ”

Eleven-Center Trial to Evaluate Technology for Superior Accuracy in IVF Embryo Selection PARSIPPAN...

12/04/2009

“DEGARELIX (FIRMAGON^®) VS LEUPROLIDE (LUPRON DEPOT^®) IN PATIENTS WITH ADVANCED PROSTATE CANCER: FURTHER ANALYSIS FROM A PHASE III PIVOTAL TRIAL”

Investigators Presented Results at the Society of Urologic Oncology Annual Meeting BETHESDA, MD &nd...

10/20/2009

“RESEARCH COMPARES MENOPUR^® WITH rFSH IN GNRH ANTAGONIST IVF CYCLES”

Ferring Pharmaceuticals Presents Study Results at American Society for Reproductive Medicine Annual ...

08/31/2009

“RECENTLY PUBLISHED STUDY DEMONSTRATES PHARMACOKINETIC ADVANTAGES OF ENDOMETRIN^® OVER CRINONE^® FOR PROGESTERONE SUPPLEMENTATION”

Study Published Online in Fertility & Sterility PARSIPPANY, NJ – August 31, 2009 – ...

08/04/2009

“FERRING PHARMACEUTICALS ANNOUNCES TRADE NAME FIRMAGON^® (degarelix for injection) FOR ADVANCED PROSTATE CANCER TREATMENT”

PARSIPPANY, NJ – August 4, 2009 – Ferring Pharmaceuticals announced today that the U.S. ...

05/13/2009

“FERRING PHARMACEUTICALS UNVEILS SIX-MONTH EFFICACY DATA FOR EUFLEXXA^® FOR THE TREATMENT OF OSTEOARTHRITIS KNEE PAIN”

Results Show Superior Decrease in Pain Scores Compared to Saline PARSIPPANY, NJ – May 13, 200...

04/27/2009

“FERRING PHARMACEUTICALS LAUNCHES PHASE IIIB TRIAL OF DEGARELIX AS INTERMITTENT THERAPY”

Trial Will Build on Pivotal Phase III Study for the Treatment of Advanced Prostate Cancer PARSIPPAN...

04/27/2009

“FERRING PHARMACEUTICALS AND RESOLVE: THE NATIONAL INFERTILITY ASSOCIATION JOIN TOGETHER TO LAUNCH NURSE LIAISON PROGRAM ”

Program to Launch During RESOLVE’s National Infertility Awareness Week®, April 25 - May 2 ...

04/13/2009

“NEW APPROACH TO PROGESTERONE SUPPLEMENTATION IN ART REVEALED IN RECENTLY PUBLISHED WHITE PAPER”

Expert Panel: Vaginal Progesterone Preferred for Luteal Support in ART PARSIPPANY, NJ – Apri...

03/24/2009

“THRIVING FERRING TO OPEN NEW SITE -
PHARMACEUTICAL IS EXPANDING LOCALLY
San Diego Union-Tribune
February 10, 2009”

...

03/24/2009

“FERRING SUPPORTS A ROUNDTABLE DISCUSSION ABOUT COLLABORATIVE INFERTILITY CARE BETWEEN REPRODUCTIVE ENDOCRINOLOGISTS AND OBGYNS”

...

03/03/2009

“FERRING PHARMACEUTICALS ANNOUNCES IMMEDIATE AVAILABILITY OF DEGARELIX FOR THE TREATMENT OF ADVANCED PROSTATE CANCER”

New Drug Provides Rapid and Sustained Suppression of Testosterone PARSIPPANY, NJ – March 4, 2...

02/17/2009

“FERRING PHARMACEUTICALS ANNOUNCES THREE STUDENT WINNERS OF TERRY MCMORROW SCHOLARSHIPS”

Parsippany, NJ – February 17, 2009 – Ferring Pharmaceuticals has announced the three lo...

12/24/2008

“FDA APPROVES FERRING PHARMACEUTICALS' DEGARELIX (generic name) FOR TREATMENT OF ADVANCED PROSTATE CANCER”

FOR IMMEDIATE RELEASE CONTACT: Tara Fisher Kovak-Likly Communications 203-762-8833, tfisher@klcpr.c...

04/09/2008

“WIN A $10,000 EDUCATION FUND FOR YOUR MIRACLE CHILD”

Contact: Christine Stroup FOR IMMEDIATE RELEASE Kovak-Likly Communications (203) 762-8833 or CStroup...

04/18/2007

“FERRING REPORTS ON ENDOMETRIN^® PRESENTATIONS AT PACIFIC COAST REPRODUCTIVE SOCIETY ANNUAL MEETING”

CONTACT: Andrea Preston FOR IMMEDIATE RELEASE Kovak-Likly Communications 203-762-8833, apreston@klcp...

06/07/2006

“COMPARATIVE STUDY SHOWS SAFER, MORE CONTROLLED STIMULATION WITH MENOPUR^® THAN GONAL-f^® IN OVULATION INDUCTION”

CONTACT: Marilyn Seiger FOR IMMEDIATE RELEASE Kovak-Likly Communications 203-762-8833, mseiger@klcpr...

05/30/2006

“NATIONWIDE SURVEY FINDS ONLY 30 PERCENT OF PATIENTS UNDERGOING INFERTILITY TREATMENT ARE ABLE TO ADMINISTER THEIR MEDICATIONS WITH ONE INJECTION PER DAY”

CONTACT: Andrea Preston FOR IMMEDIATE RELEASE Kovak-Likly Communications 203-762-8833, apreston@klcp...

04/10/2006

“FERRING PHARMACEUTICALS ANNOUNCES EUFLEXXA™ LABELING EXTENDED TO INCLUDE ROOM TEMPERATURE STORAGE”

CONTACT: Tara Fisher FOR IMMEDIATE RELEASE Kovak-Likly Communications 203-762-8833, tfisher@klcpr.co...

02/27/2006

“WIN A $10,000 EDUCATION FUND FOR YOUR MIRACLE CHILD”

CONTACT: Christine Stroup FOR IMMEDIATE RELEASE Kovak-Likly Communications (203) 762-8833 or CStroup...

02/14/2006

“HEAD-TO-HEAD STUDY SHOWS EUFLEXXA™ HAS GREATER TOLERABILITY COMPARED TO SYNVISC^® FOR OSTEOARTHRITIS KNEE PAIN”

CONTACT: Tara Fisher FOR IMMEDIATE RELEASE Kovak-Likly Communications 203-762-8833, tfisher@klcpr.co...

02/14/2006

“FERRING PHARMACEUTICALS ANNOUNCES BRUCE JENNER AS NATIONAL SPOKESPERSON FOR EUFLEXXA™”

CONTACT: Tara Fisher FOR IMMEDIATE RELEASE Kovak-Likly Communications 203-762-8833, tfisher@KLCpr.co...

11/14/2005

“FERRING PHARMACEUTICALS ANNOUNCES LAUNCH OF EUFLEXXA™ FOR OSTEOARTHRITIS KNEE PAIN”

Contact: Kelly Laban FOR IMMEDIATE RELEASE Kovak-Likly Communications (203) 762-8833 x15 or KLaban@...

07/19/2005

“FERRING PHARMACEUTICALS OBTAINS RIGHTS TO EUFLEXXA™”

Enters Co-Promotion Agreement with Savient Contact: Kelly Laban Kovak-Li...

05/20/2005

“WIN A $10,000 EDUCATION FUND FOR YOUR MIRACLE CHILD”

Ferring Pharmaceuticals Announces 2005 My Little Miracle Essay Contest Contact: ...

05/11/2005

“FERRING PHARMACEUTICALS APPOINTS WILLIAM GARBARINI AS SENIOR DIRECTOR OF MARKETING”

Responsible for Marketing for Newly Created Orthopedics/Urology Business Unit Contact: ...

05/11/2005

“FERRING PHARMACEUTICALS APPOINTS OLIVIER DELANNOY AS VICE PRESIDENT, INFERTILITY BUSINESS UNIT”

Contact: Kelly Laban Kovak-Likly Communications (203)762-8833 x15 o...

04/11/2005

“FERRING PHARMACEUTICALS ANNOUNCES LAUNCH OF NEW TREATMENT FOR INFERTILITY”

MENOPUR® (menotropins for injection, USP) First Gonadotropin to Receive FDA Approval Based on Pr...

01/11/2005

“MICHAEL SECKLER APPOINTED NATIONAL SALES DIRECTOR FOR FERRING PHARMACEUTICALS”

Contact: Kelly Laban Kovak-Likly Communications (203)762-8833 x15 o...

12/10/2004

“LOCAL WOMAN WINS $1,000 FOR HER 19-MONTH-OLD SON”

Monroe Resident Wins Honorable Mention Prize for Ferring’s My Little Miracle Essay Contest ...

12/10/2004

“GEORGIA REPRODUCTIVE SPECIALISTS CELEBRATES WITH ITS PATIENT NAMED AS WINNER OF FERRING'S MY LITTLE MIRACLE ESSAY CONTEST”

Ferring Presents $1,000 to Local Honorable Mention Winner Contact: Kelly Laban ...

12/10/2004

“LOCAL MAN WINS $5,000 FOR HIS 11-MONTH-OLD CHILDREN”

Northville Resident Wins Runner-Up Prize in Ferring’s My Little Miracle Essay Contest ...

12/10/2004

“OAK BROOK FERTILITY CELEBRATES WITH ITS PATIENT NAMED AS WINNER OF FERRING'S MY LITTLE MIRACLE ESSAY CONTEST”

Ferring Presents $1,000 to Local Honorable Mention Winner Contact: Kelly Laban...

12/10/2004

“FAMILY BEGINNINGS CELEBRATES WITH ITS PATIENTS NAMED AS WINNERS OF FERRING'S MY LITTLE MIRACLE ESSAY CONTEST”

Ferring Presents $3,000 in Prizes to Honorable Mention Winners Contact: ...

12/08/2004

“LOCAL FERTILITY PRACTICE CELEBRATES PATIENT NAMED AS WINNER OF FERRING'S MY LITTLE MIRACLE ESSAY CONTEST”

Ferring Presents $1,000 to Honorable Mention Winner Contact: Kelly Laban ...

10/18/2004

“FERRING PRESENTS $10,000 GRAND PRIZE TO WINNER OF MY LITTLE MIRACLE ESSAY CONTEST”

Contest Winner Announced at ASRM Contact: Kelly Laban Kovak-Likly Communi...

10/18/2004

“SOCIETY FOR REPRODUCTIVE ENDOCRINOLOGY AND INFERTILITY ANNOUNCES FERRING PHARMACEUTICALS' SPONSORSHIP OF FELLOWS' RETREAT 2005-2007”

Contact: Kelly Laban Kovak-Likly Communications (203)762-8833 or KLaba...

10/18/2004

“FERRING INTRODUCES BRAVELLE^® WITH FIRST NEEDLE-FREE RECONSTITUTION DEVICE”

Q·Cap™ Previewed at Annual ASRM Meeting Contact: Kelly Laban ...

10/18/2004

“FERRING SUPPORTS SYMPOSIUM ON OPTIMIZING ASSISTED REPRODUCTIVE TECHNOLOGY (ART)”

Held at 60th Annual Meeting of the American Society for Reproductive Medicine Contact: ...

07/21/2004

“WIN A $10,000 EDUCATION FUND FOR YOUR MIRACLE CHILD”

Ferring Pharmaceuticals Announces My Little Miracle Essay Contest Contact:Kelly LabanKovak-Likly ...

04/28/2004

“RESULTS OF EMBRACE* TRIALS PRESENTED AT THE PACIFIC COAST REPRODUCTIVE SOCIETY MEETING”

First-Ever Systematic Evaluation of Mixed Protocols in IVF Contact: Marilyn Seiger ...

02/10/2003

“CLINICAL STUDY CONFIRMS EFFECTIVENESS OF FERRING'S NEW BRAVELLE^® IN PRODUCING DONOR EGGS FOR IVF”

Study appears in Today’s Therapeutic Trends Contact: Marilyn Seiger Kovak-Lik...

12/19/2002

“FDA APPROVES BRAVELLE™ FOR IN VITRO FERTILIZATION”

Clinical Trial Demonstrates State-of-the-Art Performance With Significantly Less Injection Site Pain...

11/11/2002

“THE AMERICAN INFERTILITY ASSOCIATION, RESOLVE AND FERRING TEAM UP TO IMPROVE ACCESS TO INFERTILITY TREATMENT”

Contact: Kelly Laban Kovak-Likly Communications 203.762.8833 or Klaban@KLCpr.com TARRYTOWN, NY &n...

06/10/2002

“CLINICAL STUDY SUPPORTS IVF INDICATION FOR FERRING'S NEW BRAVELLE™ (urofollitropin for injection, purified)”

Study appears in June issue of Fertility and Sterility TARRYTOWN, NY – June 10, 2002 – ...

05/06/2002

“FDA APPROVES BRAVELLE™ (urofollitropin for injection, purified) FERRING\’S NEW HUMAN-DERIVED FOLLICLE-STIMULATING HORMONE FOR INFERTILITY TREATMENT”

New Highly Purified Alternative To Genetically Engineered Infertility Treatments CONTACT: Marilyn...

04/29/2002

The Ferring USA Product Line